TheraRadar

Competitive Landscape by Indication

Data updated: Jun 28, 2026

158 indications, 116,207 trials mapped

Oncology

54,621 trials
Solid Tumor (Advanced)
9480 trials 871 Ph3
Merck, Sichuan Baili Pharmaceutical Co., Ltd., Eli Lilly
Breast Cancer
3932 trials 703 Ph3
AstraZeneca, Roche, Pfizer
Non-Hodgkin Lymphoma
3886 trials 346 Ph3
Roche, Merck, Genmab
NSCLC
3387 trials 551 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
Colorectal Cancer
2576 trials 360 Ph3
AbbVie, AstraZeneca, Revolution Medicines, Inc.
Prostate Cancer
2287 trials 351 Ph3
Novartis, AstraZeneca, Jiangsu HengRui Medicine Co., Ltd.
Multiple Myeloma
1923 trials 231 Ph3
Johnson & Johnson, GSK, AbbVie
AML
1803 trials 169 Ph3
AbbVie, Taiho Oncology, Inc., Kura Oncology, Inc.
Hematologic Malignancies
1711 trials 151 Ph3
Johnson & Johnson, Novartis, Orca Biosystems, Inc.
Melanoma
1655 trials 138 Ph3
Bristol-Myers Squibb, Merck, Novartis
Pancreatic Cancer
1562 trials 136 Ph3
Revolution Medicines, Inc., AstraZeneca, Astellas
Hepatocellular Carcinoma
1407 trials 216 Ph3
AstraZeneca, Akeso, Roche
Ovarian Cancer
1382 trials 159 Ph3
AstraZeneca, AbbVie, Genmab
Lung Cancer (General)
1304 trials 168 Ph3
Chongqing Precision Biotech Co., Ltd, AstraZeneca, Avistone Biotechnology Co., Ltd.
Head and Neck Cancer
1232 trials 112 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., AstraZeneca, Rakuten Medical, Inc.
MDS
1176 trials 95 Ph3
Bristol-Myers Squibb, Takeda, Taiho Oncology, Inc.
Gastric Cancer
1073 trials 183 Ph3
AstraZeneca, Astellas, Chongqing Precision Biotech Co., Ltd
Sarcoma
1045 trials 73 Ph3
USWM CT, LLC, Hansoh BioMedical R&D Company, Eli Lilly
Bladder Cancer
975 trials 135 Ph3
Merck, AstraZeneca, Pfizer
Glioblastoma
971 trials 64 Ph3
Novartis, GT Medical Technologies, Inc., Philogen S.p.A.
ALL
938 trials 90 Ph3
Novartis, Amgen, Chongqing Precision Biotech Co., Ltd
Brain Tumor
786 trials 55 Ph3
Pfizer, InSightec, Jazz Pharmaceuticals
Esophageal Cancer
782 trials 133 Ph3
AstraZeneca, Merck, Sichuan Baili Pharmaceutical Co., Ltd.
CLL
772 trials 82 Ph3
BeOne Medicines, Acerta Pharma BV, AbbVie
Renal Cell Carcinoma
770 trials 72 Ph3
Merck, Exelixis, Bristol-Myers Squibb
Squamous Cell Carcinoma
639 trials 63 Ph3
Regeneron, Merck, AstraZeneca
Triple Negative Breast Cancer
592 trials 66 Ph3
Gilead, Novartis, AstraZeneca
Cholangiocarcinoma
583 trials 59 Ph3
AstraZeneca, Suzhou Suncadia Biopharmaceuticals Co., Ltd., Eli Lilly
SCLC
555 trials 71 Ph3
Amgen, Boehringer Ingelheim, Merck
Cervical Cancer
530 trials 89 Ph3
AstraZeneca, Merck, Shanghai Bovax Biotechnology Co., Ltd.
Hodgkin Lymphoma
479 trials 36 Ph3
Merck, Takeda, Tessa Therapeutics
Endometrial Cancer
457 trials 48 Ph3
AstraZeneca, Merck, Genmab
CML
398 trials 44 Ph3
Novartis, Shenzhen TargetRx Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd.
Neuroendocrine Tumors
326 trials 42 Ph3
Advanced Accelerator Applications, Crinetics Pharmaceuticals Inc., Merck
Myelofibrosis
282 trials 35 Ph3
Novartis, Bristol-Myers Squibb, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Mesothelioma
276 trials 17 Ph3
Novartis, AstraZeneca, TCR2 Therapeutics
Thyroid Cancer
226 trials 34 Ph3
Exelixis, Eli Lilly, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HER2+ Breast Cancer
185 trials 32 Ph3
Sichuan Baili Pharmaceutical Co., Ltd., Roche, Jazz Pharmaceuticals
HER2- Breast Cancer
177 trials 19 Ph3
AstraZeneca, Novartis, BeOne Medicines
Merkel Cell Carcinoma
101 trials 6 Ph3
TuHURA Biosciences, Inc., ImmunityBio, Inc., AstraZeneca

CNS

10,395 trials
Major Depression
1765 trials 473 Ph3
Neurocrine Biosciences, Johnson & Johnson, Neumora Therapeutics, Inc.
Alzheimer's Disease
1519 trials 290 Ph3
Eli Lilly, Bristol-Myers Squibb, Roche
Schizophrenia
940 trials 252 Ph3
Neurocrine Biosciences, Luye Pharma Group Ltd., Bristol-Myers Squibb
Parkinson's Disease
925 trials 172 Ph3
iRegene Therapeutics Co., Ltd., Roche, Luye Pharma Group Ltd.
Multiple Sclerosis
862 trials 233 Ph3
Roche, Novartis, Sanofi
Migraine
511 trials 194 Ph3
AbbVie, Pfizer, H. Lundbeck A/S
Epilepsy
466 trials 170 Ph3
Praxis Precision Medicines, UCB Biopharma SRL, Biohaven Therapeutics Ltd.
Anxiety
459 trials 104 Ph3
VistaGen Therapeutics, Inc., Beijing Union Pharmaceutical Factory Ltd, Definium Therapeutics US, Inc.
Alcohol Use Disorder
444 trials 72 Ph3
Eli Lilly, Pop Test Oncology LLC, Newleos Therapeutics, Inc.
Opioid Use Disorder
426 trials 91 Ph3
Go Medical Industries Pty Ltd, Akyso Therapeutics, LLC, Eli Lilly
ALS
346 trials 71 Ph3
Eli Lilly, Biogen, Amylyx Pharmaceuticals Inc.
Autism Spectrum Disorder
336 trials 64 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Curemark
ADHD
333 trials 118 Ph3
Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim, Bazelet Nehushtan LtD.
PTSD
306 trials 61 Ph3
Oui Therapeutics, Inc., COMPASS Pathways, Senseye, Inc.
Bipolar Disorder
288 trials 96 Ph3
Intra-Cellular Therapies, Inc., Bristol-Myers Squibb, Xenon Pharmaceuticals Inc.
Neuropathy
279 trials 70 Ph3
argenx, WinSanTor, Inc, Rinri Therapeutics
Huntington's Disease
106 trials 18 Ph3
Roche, Skyhawk Therapeutics, Inc., Novartis
OCD
84 trials 11 Ph3
Vericel Corporation, Biohaven Pharmaceuticals, Inc., Roche

Click any indication to see full competitive landscape (all sponsors, trials, phases).

Data: ClinicalTrials.gov | Mapping: Indication Taxonomy